Search results
Repurposed cancer drug could treat diabetes by nudging pancreatic acinar cells to produce insulin
Medical Xpress· 11 hours agoIn normal mice and humans, the blood sugar-regulating hormone insulin is produced by beta cells,...
Today's NYT Wordle Hints & Answer - Help for May 7, #1053 - CNET
CNET· 5 hours agoToday's Wordle answer is a common word, but not all of its letters are exceptionally common....
Estimating The Intrinsic Value Of DSW Capital plc (LON:DSW)
Simply Wall St. via Yahoo Finance· 42 minutes agoCapital as potential shareholders, the cost of equity is used as the discount rate, rather than the...
Xeris Biopharma and Beta Bionics join forces to develop dual-hormone pump for diabetes
Proactive Investors· 22 hours agoXeris Biopharma Holdings (NASDAQ:XERS) and Beta Bionics have announced an exclusive worldwide...
Active ETFs: The Death of Smart Beta?
etf.com via Yahoo Finance· 20 hours agoThe rise of active ETFs in Europe has sparked questions about the role of smart beta within multi-asset portfolios, an asset class that has struggled to...
Is Schwab Fundamental U.S. Large Company Index ETF (FNDX) a Strong ETF Right Now?
Zacks via Yahoo Finance· 22 hours agoMaking its debut on 08/13/2013, smart beta exchange traded fund Schwab Fundamental U.S. Large...
A Look At The Intrinsic Value Of SSP Group plc (LON:SSPG)
Simply Wall St. via Yahoo Finance· 2 hours agoIn this calculation we've used 11%, which is based on a levered beta of 1.759. Beta is a measure of...
iOS 17.5 Beta 4: Your iPhone Could Get These New Features Soon
CNET· 6 days agoApple released the fourth iOS 17.5 beta to public beta testers on Wednesday, a day after the company...
iSpecimen Inc (ISPC): A Technical Analysis – News Heater
NewsHeater· 2 hours agoISPC has 36-month beta value of 1.48. The public float for ISPC is 5.34M, and currently, short sellers hold a 1.33% ratio of that float. The average trading volume of ISPC on May 07, 2024 was 864.25K shares.
Xeris Biopharma inks deal for diabetes pump technology By Investing.com
Investing.com· 13 hours agoXeris Biopharma Holdings, Inc. (NASDAQ:XERS), a biopharmaceutical company, announced today its...
